Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Recruiting

DorzolamideOcular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Sponsor:

University Health Network, Toronto

Code:

NCT00152932

Conditions

Glaucoma

Eligibility Criteria

Sex: All

Age: 20 - 70+

Healthy Volunteers: Not accepted

Interventions

Dorzolamide 2% drops

HRF and CLBF

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-30. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2007-07-25.